[Federal Register Volume 61, Number 172 (Wednesday, September 4, 1996)]
[Notices]
[Page 46632]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-22479]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Pharmacoeconomic Center Notice Regarding Use of Drugs for 
Unlabeled Applications

AGENCY: Department of Defense Pharmacoeconomic Center.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Pharmacoeconomic Center (PEC) announces as a matter of 
policy that Food and Drug Administration (FDA) approved drugs may be 
used, where appropriate, for unlabeled indications. It is the further 
intent of the Department of Defense (DoD) that such drugs may be 
included, where appropriate, in disease state analyses which may result 
in their selection to the Tri-Service Formulary and promotion for a 
given disease state.

FOR FURTHER INFORMATION CONTACT:
Captain Charles S. Reeves, USN, DoD Pharmacoeconomic Center, Fort Sam 
Houston, Texas 78234, (210) 221-5596.

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act, 21 U.S.C. 352(f) et seq., notice is given that pharmacies on DoD 
installations will, as a matter of policy, fill prescriptions in 
appropriate cases with drugs that are not necessarily approved by the 
FDA for the treatment of the underlying medical condition but have 
nonetheless been proven effective for treatment of the disease state in 
question.
Errol L. Moran,
Director, Pharmacoeconomic Center.
[FR Doc. 96-22479 Filed 9-3-96; 8:45 am]
BILLING CODE 3710-08-M